Cargando…

The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis

Detalles Bibliográficos
Autor principal:	Galassi, Giuliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244153/ https://www.ncbi.nlm.nih.gov/pubmed/35759066 http://dx.doi.org/10.1007/s10072-022-06206-5

Ejemplares similares

Reply to Letter response to “The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis”
por: Galassi, Giuliana, et al.
Publicado: (2022)

Letter response to “The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis”
por: Nóbrega, Paulo Ribeiro, et al.
Publicado: (2022)

Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review
por: Rodrigues, Cleonisio Leite, et al.
Publicado: (2022)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
por: Fanella, Gaia, et al.
Publicado: (2022)

Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab
por: Mimori, Masahiro, et al.
Publicado: (2022)

Isolated COVID-19 Infection Precipitates Myasthenia Gravis Crisis: A Case Report
por: Moschella, Phillip, et al.
Publicado: (2020)

Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19
por: Scopelliti, Giuseppe, et al.
Publicado: (2020)

Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
por: Ricciardi, Dario, et al.
Publicado: (2021)

An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
por: Wang, H.Y., et al.
Publicado: (2023)

Myasthenia Gravis Presenting with Myasthenic Crisis Mimicking Status Asthmatics
por: Kubo, Hitoshi, et al.
Publicado: (2021)

Predictive factors for postoperative myasthenic crisis in patients with myasthenia gravis
por: Wei, Bohua, et al.
Publicado: (2023)

A mild course of COVID-19 infection in a generalized Myasthenia gravis patient under eculizumab treatment
por: Alis, Ceren, et al.
Publicado: (2022)

COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation
por: Trinchillo, Assunta, et al.
Publicado: (2022)

COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined
por: Kim, Sohyeon, et al.
Publicado: (2023)

Myasthenic Crisis as the First Presentation of Myasthenia Gravis: A Case Report
por: Payus, Alvin Oliver, et al.
Publicado: (2021)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis
por: Ozyurt Kose, Selen, et al.
Publicado: (2023)

Favorable outcome of COVID-19 infection in a patient with congenital myasthenic syndrome
por: Bonanno, Silvia, et al.
Publicado: (2021)

Patients With Myasthenia Gravis With Acute Onset of Dyspnea: Predictors of Progression to Myasthenic Crisis and Prognosis
por: Huang, Yangyu, et al.
Publicado: (2021)

Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: A 17-year experience
por: Soleimani, Ali, et al.
Publicado: (2004)

Tracheoesophageal Fistula Caused by Tracheostomy in a Patient with Myasthenia Gravis after a Myasthenic Crisis
por: Jiaxin, Chen, et al.
Publicado: (2017)

Classification of myasthenia gravis and congenital myasthenic syndromes in dogs and cats
por: Mignan, Thomas, et al.
Publicado: (2020)

Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients
por: Nelke, Christopher, et al.
Publicado: (2022)

Analysis of influencing factors of postoperative myasthenic crisis in 564 patients with myasthenia gravis in a single center
por: Jiao, Peng, et al.
Publicado: (2023)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

A Patient with Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome
por: Kim, Jee-Ae, et al.
Publicado: (2012)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
por: Kojima, N., et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan
por: Fine, Sydney, et al.
Publicado: (2022)

Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report
por: Jaijakul, Siraya
Publicado: (2020)

Portal Vein Thrombosis—a Rare Complication of SARS-CoV-2 Infection
por: Sharma, Neeraj, et al.
Publicado: (2021)

SARS-CoV-2 N95 contamination worn under a face shield, via medical mask surrogate, in healthcare providers treating COVID-19
por: Graves, Amanda, et al.
Publicado: (2022)

The Modified National Early Warning Score (m-NEWS) for COVID-19-Infected Patient Evaluation: a Proof-of-Concept
por: Galassi, Luca, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome: an atypical neurological manifestation of SARS-CoV-2 infection
por: Gasparotto, Michela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f0cdr9vh20u30tgosjth79fuqr